TrialTransplantation2017

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.

Jakob Mühlbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.